Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shore Capital Partners is a Chicago-based private equity firm focused on investing in microcap and lower middle-market companies, with a significant emphasis on healthcare (including biotech-enabled services, medical device outsourcing, and medical spas), food & beverage, real estate, business services, and industrials[5][9]. The firm does not discover or develop drugs or biologics, but rather provides growth capital, operational support, and acquisition expertise to small and medium-sized businesses, many of which are in life science, healthcare services, or adjacent sectors[1][2]. Their approach is to identify industry niches, recruit industry leaders, and partner with entrepreneurs to drive transformational growth through both organic initiatives and strategic acquisitions[2][9].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shore Capital Partners.